Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis

Vladimir Riabov1,2, Alexandru Gudima3, Nan Wang1, Amanda Mickley3, Alexander N. Orekhov2, Julia Kzhyshkowska3,2
1Department of Dermatology, University Medical Center and Medical Faculty Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim, Germany
2Department of Nanopathology, Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow, Russia
3Department of Innate Immunity and Tolerance, University Medical Center and Medical Faculty Mannheim, Institute of Transfusion Medicine and Immunology, Ruprecht-Karls University of Heidelberg, Mannheim, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

Algars, 2012, Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients, Int. J. Cancer, 131, 864, 10.1002/ijc.26457

Allavena, 2008, The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages, Crit. Rev. Oncol. Hematol, 66, 1, 10.1016/j.critrevonc.2007.07.004

Allin, 2012, Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population, Br. J. Cancer, 106, 199, 10.1038/bjc.2011.501

Arakane, 2010, Insect chitinase and chitinase-like proteins, Cell. Mol. Life Sci, 67, 201, 10.1007/s00018-009-0161-9

Basire, 2006, High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors, Thromb. Haemost, 95, 678, 10.1160/TH05-07-0511

Bergers, 2000, Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis, Nat. Cell Biol, 2, 737, 10.1038/35036374

Bijnsdorp, 2011, Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors, Br. J. Cancer, 104, 1185, 10.1038/bjc.2011.74

Bingle, 2002, The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies, J. Pathol, 196, 254, 10.1002/path.1027

Bjorndahl, 2005a, Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis, Cancer Res, 65, 9261, 10.1158/0008-5472.CAN-04-2345

Bjorndahl, 2005b, Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo, Proc. Natl. Acad. Sci. U.S.A, 102, 15593, 10.1073/pnas.0507865102

Brecht, 2011, Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2, FASEB J, 25, 2408, 10.1096/fj.10-179473

Burke, 2002, Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy, J. Pathol, 196, 204, 10.1002/path.1029

Cao, 1998, Vascular endothelial growth factor C induces angiogenesis in vivo, Proc. Natl. Acad. Sci. U.S.A, 95, 14389, 10.1073/pnas.95.24.14389

Casazza, 2013, Impeding macrophage entry into hypoxic tumor areas by sema3a/Nrp1 Signaling blockade inhibits angiogenesis and restores antitumor immunity, Cancer Cell, 24, 695, 10.1016/j.ccr.2013.11.007

Chen, 2003, Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer, Clin. Cancer Res, 9, 729

Chen, 2011, Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner, Clin. Cancer Res, 17, 7230, 10.1158/1078-0432.CCR-11-1354

Chen, 2012, Macrophage-induced tumor angiogenesis is regulated by the TSC2-mTOR pathway, Cancer Res, 72, 1363, 10.1158/0008-5472.CAN-11-2684

Coffelt, 2011, Angiopoietin 2 stimulates TIE2-expressing monocytes to suppress T cell activation and to promote regulatory T cell expansion, J. Immunol, 186, 4183, 10.4049/jimmunol.1002802

Coffelt, 2009, Tumor-associated macrophages: effectors of angiogenesis and tumor progression, Biochim. Biophys. Acta, 1796, 11, 10.1016/j.bbcan.2009.02.004

Coffelt, 2010, Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions, Cancer Res, 70, 5270, 10.1158/0008-5472.CAN-10-0012

Cursiefen, 2004, VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment, J. Clin. Invest, 113, 1040, 10.1172/JCI20465

David, 2012, Stabilin-1 expression in tumor associated macrophages, Brain Res, 1481, 71, 10.1016/j.brainres.2012.08.048

De Palma, 2013, A new twist on radiation oncology: low-dose irradiation elicits immunostimulatory macrophages that unlock barriers to tumor immunotherapy, Cancer Cell, 24, 559, 10.1016/j.ccr.2013.10.019

De Palma, 2005, Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors, Cancer Cell, 8, 211, 10.1016/j.ccr.2005.08.002

Detry, 2012, Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase, Blood, 119, 5048, 10.1182/blood-2011-12-400267

Ding, 2012, The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer, Mol. Med. Rep, 6, 1023, 10.3892/mmr.2012.1043

Du, 2008, HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion, Cancer Cell, 13, 206, 10.1016/j.ccr.2008.01.034

Duong, 2012, Tumor lymphangiogenesis as a potential therapeutic target, J. Oncol, 2012, 204946, 10.1155/2012/204946

Egami, 2003, Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth, J. Clin. Invest, 112, 67, 10.1172/JCI16645

Espinosa, 2011, CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis, Am. J. Pathol, 179, 2100, 10.1016/j.ajpath.2011.06.021

Eubank, 2003, M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes, J. Immunol, 171, 2637, 10.4049/jimmunol.171.5.2637

Eubank, 2011, Opposing roles for HIF-1alpha and HIF-2alpha in the regulation of angiogenesis by mononuclear phagocytes, Blood, 117, 323, 10.1182/blood-2010-01-261792

Faibish, 2011, A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers, Mol. Cancer Ther, 10, 742, 10.1158/1535-7163.MCT-10-0868

Forssell, 2007, High macrophage infiltration along the tumor front correlates with improved survival in colon cancer, Clin. Cancer Res, 13, 1472, 10.1158/1078-0432.CCR-06-2073

Francescone, 2011, Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma, J. Biol. Chem, 286, 15332, 10.1074/jbc.M110.212514

Francescone, 2013, Tumor-derived mural-like cells coordinate with endothelial cells: role of YKL-40 in mural cell-mediated angiogenesis, Oncogene, 10.1038/onc.2013.160

Galarneau, 2007, Increased glioma growth in mice depleted of macrophages, Cancer Res, 67, 8874, 10.1158/0008-5472.CAN-07-0177

Giraudo, 2004, An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis, J. Clin. Invest, 114, 623, 10.1172/JCI200422087

Gomes, 2013, Tumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanisms, Life Sci, 92, 101, 10.1016/j.lfs.2012.10.008

Gordon, 2010, Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation, Development, 137, 3899, 10.1242/dev.050021

Gratchev, 2006, Mphi1 and Mphi2 can be re-polarized by Th2 or Th1 cytokines, respectively, and respond to exogenous danger signals, Immunobiology, 211, 473, 10.1016/j.imbio.2006.05.017

Gratchev, 2008, Expression of osteoarthritis marker YKL-39 is stimulated by transforming growth factor beta (TGF-beta) and IL-4 in differentiating macrophages, Biomark. Insights, 3, 39, 10.1177/117727190800300003

Halin, 2009, Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model, Neoplasia, 11, 177, 10.1593/neo.81338

Harbeck, 2002, Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts, Clin. Breast Cancer, 3, 196, 10.3816/CBC.2002.n.023

Harutyunyan, 2012, The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure, Immunobiology, 217, 652, 10.1016/j.imbio.2011.11.003

Harutyunyan, 2013, Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial, Immunobiology, 218, 945, 10.1016/j.imbio.2012.10.015

He, 2012, Endothelial cells provide an instructive niche for the differentiation and functional polarization of M2-like macrophages, Blood, 120, 3152, 10.1182/blood-2012-04-422758

Heindl, 2010, Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?, Ophthalmology, 117, 334, 10.1016/j.ophtha.2009.06.057

Hildenbrand, 1995, Urokinase and macrophages in tumour angiogenesis, Br. J. Cancer, 72, 818, 10.1038/bjc.1995.419

Hirakawa, 2005, VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis, J. Exp. Med, 201, 1089, 10.1084/jem.20041896

Hong, 2009, Induced interleukin-8 expression in gliomas by tumor-associated macrophages, J. Neurooncol, 93, 289, 10.1007/s11060-008-9786-z

Hong, 2004, VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins, FASEB J, 18, 1111, 10.1096/fj.03-1179fje

Hotchkiss, 2003, Thymidine phosphorylase and 2-deoxyribose stimulate human endothelial cell migration by specific activation of the integrins alpha 5 beta 1 and alpha V beta 3, J. Biol. Chem, 278, 19272, 10.1074/jbc.M212670200

Huang, 2011, Specifically targeting angiopoietin-2 inhibits angiogenesis, Tie2-expressing monocyte infiltration, and tumor growth, Clin. Cancer Res, 17, 1001, 10.1158/1078-0432.CCR-10-2317

Huang, 2002, Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice, J. Natl. Cancer Inst, 94, 1134, 10.1093/jnci/94.15.1134

Imtiyaz, 2010, Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation, J. Clin. Invest, 120, 2699, 10.1172/JCI39506

Ito, 2011, Lymphangiogenesis and axillary lymph node metastases correlated with VEGF-C expression in two immunocompetent mouse mammary carcinoma models, Int. J. Breast Cancer, 2011, 867152, 10.4061/2011/867152

Jensen, 2003, High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer, Clin. Cancer Res, 9, 4423

Jensen, 2013, Plasma YKL-40: a potential biomarker for psoriatic arthritis?, J. Eur. Acad. Dermatol. Venereol, 27, 815, 10.1111/j.1468-3083.2012.04570.x

Jeon, 2008, Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer, Cancer Res, 68, 1100, 10.1158/0008-5472.CAN-07-2572

Jeon, 2007, Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis, J. Leukoc. Biol, 81, 557, 10.1189/jlb.0806517

Johansen, 2003, High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival, Breast Cancer Res. Treat, 80, 15, 10.1023/A:1024431000710

Johansen, 2009, Plasma YKL-40: a potential new cancer biomarker?, Future Oncol, 5, 1065, 10.2217/fon.09.66

Joukov, 1997, Proteolytic processing regulates receptor specificity and activity of VEGF-C, EMBO J, 16, 3898, 10.1093/emboj/16.13.3898

Jung, 2003, IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis, FASEB J, 17, 2115, 10.1096/fj.03-0329fje

Karikoski, 2009, Clever-1/Stabilin-1 regulates lymphocyte migration within lymphatics and leukocyte entrance to sites of inflammation, Eur. J. Immunol, 39, 3477, 10.1002/eji.200939896

Kastrup, 2011, Can YKL-40 be a new inflammatory biomarker in cardiovascular disease?, Immunobiology, 217, 483, 10.1016/j.imbio.2011.04.007

Kawahara, 2010, Infiltration of thymidine phosphorylase-positive macrophages is closely associated with tumor angiogenesis and survival in intestinal type gastric cancer, Oncol. Rep, 24, 405, 10.3892/or_00000873

Kerjaschki, 2005, The crucial role of macrophages in lymphangiogenesis, J. Clin. Invest, 115, 2316, 10.1172/JCI26354

Kim, 2007, Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer, World J. Surg. Oncol, 5, 17, 10.1186/1477-7819-5-17

Kioi, 2010, Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice, J. Clin. Invest, 120, 694, 10.1172/JCI40283

Klug, 2013, Low-dose irradiation programs macrophage differentiation to an iNOS(+)/M1 phenotype that orchestrates effective T Cell immunotherapy, Cancer Cell, 24, 589, 10.1016/j.ccr.2013.09.014

Konradsen, 2013, The chitinase-like protein YKL-40: A possible biomarker of inflammation and airway remodeling in severe pediatric asthma, J. Allergy. Clin. Immunol, 132, 328, 10.1016/j.jaci.2013.03.003

Kozin, 2010, Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation, Cancer Res, 70, 5679, 10.1158/0008-5472.CAN-09-4446

Kurahara, 2011, Significance of M2-polarized tumor-associated macrophage in pancreatic cancer, J. Surg. Res, 167, e211, 10.1016/j.jss.2009.05.026

Kurahara, 2013, M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer, Pancreas, 42, 155, 10.1097/MPA.0b013e318254f2d1

Kwon, 2013, Mechanism of pro-tumorigenic effect of BMP-6: neovascularization involving tumor-associated macrophages and IL-1alpha, Prostate, 74, 121, 10.1002/pros.22734

Kzhyshkowska, 2010, Multifunctional receptor stabilin-1 in homeostasis and disease, ScientificWorldJournal, 10, 2039, 10.1100/tsw.2010.189

Kzhyshkowska, 2006b, Stabilin-1, a homeostatic scavenger receptor with multiple functions, J. Cell. Mol. Med, 10, 635, 10.1111/j.1582-4934.2006.tb00425.x

Kzhyshkowska, 2009, Cross-talk between endocytic clearance and secretion in macrophages, Immunobiology, 214, 576, 10.1016/j.imbio.2009.03.007

Kzhyshkowska, 2007, Human chitinases and chitinase-like proteins as indicators for inflammation and cancer, Biomark. Insights, 2, 128, 10.1177/117727190700200023

Kzhyshkowska, 2006c, Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway, Blood, 107, 3221, 10.1182/blood-2005-07-2843

Kzhyshkowska, 2006a, Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of, SPARC, J. Immunol, 176, 5825, 10.4049/jimmunol.176.10.5825

Lambaerts, 2009, The signaling mechanisms of syndecan heparan sulfate proteoglycans, Curr. Opin. Cell Biol, 21, 662, 10.1016/j.ceb.2009.05.002

Laoui, 2013, Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population, Cancer Res, 74, 24, 10.1158/0008-5472.CAN-13-1196

Lee, 2005, Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors, J. Cell Biol, 169, 681, 10.1083/jcb.200409115

Leek, 1998, Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma, Br. J. Cancer, 77, 2246, 10.1038/bjc.1998.373

Leek, 1996, Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma, Cancer Res, 56, 4625

Lewis, 2007, Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2, Cancer Res, 67, 8429, 10.1158/0008-5472.CAN-07-1684

Lewis, 2000, Expression of vascular endothelial growth factor by macrophages is up- regulated in poorly vascularized areas of breast carcinomas, J. Pathol, 192, 150, 10.1002/1096-9896(2000)9999:9999%3C::AID-PATH687%3E3.0.CO;2-G

Lin, 2006, Macrophages regulate the angiogenic switch in a mouse model of breast cancer, Cancer Res, 66, 11238, 10.1158/0008-5472.CAN-06-1278

Lohela, 2009, VEGFs and receptors involved in angiogenesis versus lymphangiogenesis, Curr. Opin. Cell Biol, 21, 154, 10.1016/j.ceb.2008.12.012

Ly, 2010, In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages, J. Immunol, 185, 3481, 10.4049/jimmunol.0903479

Mantovani, 1992, The origin and function of tumor-associated macrophages, Immunol. Today, 13, 265, 10.1016/0167-5699(92)90008-U

Mantovani, 2007, Inflammation and cancer: breast cancer as a prototype, Breast, 16, S27, 10.1016/j.breast.2007.07.013

Martens, 2006, Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis, J. Pathol, 208, 574, 10.1002/path.1921

Matsubara, 2013, TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis, Hepatology, 57, 1416, 10.1002/hep.25965

Mazzieri, 2011, Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells, Cancer Cell, 19, 512, 10.1016/j.ccr.2011.02.005

McColl, 2003, Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D, J. Exp. Med, 198, 863, 10.1084/jem.20030361

Medina, 2011, Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8, Mol. Med, 17, 1045, 10.2119/molmed.2011.00129

Mistrangelo, 2013, A novel biomarker-based analysis reliably predicts nodal metastases in anal carcinoma: preliminary evidence of therapeutic impact, Colorectal Dis, 15, 1382, 10.1111/codi.12289

Moussai, 2011, The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C, J. Invest. Dermatol, 131, 229, 10.1038/jid.2010.266

Nakamura, 2004, Inhibition of lymphangiogenesis-related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor MMI270, Cancer Sci, 95, 25, 10.1111/j.1349-7006.2004.tb03166.x

Nishie, 1999, Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas, Clin. Cancer Res, 5, 1107

Nishikawa, 2003, gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells, Exp. Cell Res, 287, 79, 10.1016/S0014-4827(03)00069-7

Ohta, 2002, Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas, Int. J. Cancer, 102, 220, 10.1002/ijc.10705

Ong, 2012, Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response, Eur. J. Immunol, 42, 89, 10.1002/eji.201141825

Piao, 2005, Involvement of urokinase-type plasminogen activator in sphingosylphosphorylcholine-induced angiogenesis, Exp. Dermatol, 14, 356, 10.1111/j.0906-6705.2005.00272.x

Pucci, 2009, A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood “resident” monocytes, and embryonic macrophages suggests common functions and developmental relationships, Blood, 114, 901, 10.1182/blood-2009-01-200931

Qian, 2010, Macrophage diversity enhances tumor progression and metastasis, Cell, 141, 39, 10.1016/j.cell.2010.03.014

Ran, 2012, Macrophage-Mediated Lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors, Cancers (Basel), 4, 618, 10.3390/cancers4030618

Rego, 2013, Breast tumor cell TACE-shed MCSF promotes pro-angiogenic macrophages through NF-kappaB signaling, Angiogenesis, 10.1007/s10456-013-9405-2

Roberts, 2006, Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2, Cancer Res, 66, 2650, 10.1158/0008-5472.CAN-05-1843

Roda, 2012, Stabilization of HIF-2alpha induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model, J. Immunol, 189, 3168, 10.4049/jimmunol.1103817

Rolny, 2011, HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF, Cancer Cell, 19, 31, 10.1016/j.ccr.2010.11.009

Roslind, 2008, YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer, Breast Cancer Res. Treat, 112, 275, 10.1007/s10549-007-9870-7

Scavelli, 2004, Crosstalk between angiogenesis and lymphangiogenesis in tumor progression, Leukemia, 18, 1054, 10.1038/sj.leu.2403355

Schledzewski, 2006, Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1(+), F4/80(+), CD11b(+) macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis, J. Pathol, 209, 67, 10.1002/path.1942

Schoppmann, 2002, Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis, Am. J. Pathol, 161, 947, 10.1016/S0002-9440(10)64255-1

Schoppmann, 2006, VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival, Surgery, 139, 839, 10.1016/j.surg.2005.12.008

Shao, 2013, YKL-40 acts as an angiogenic factor to promote tumor angiogenesis, Front. Physiol, 4, 10.3389/fphys.2013.00122

Shao, 2011, Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers, Br. J. Cancer, 105, 1203, 10.1038/bjc.2011.347

Shao, 2009, YKL-40, a secreted glycoprotein, promotes tumor angiogenesis, Oncogene, 28, 4456, 10.1038/onc.2009.292

Shieh, 2009, Tumor-associated macrophage correlated with angiogenesis and progression of mucoepidermoid carcinoma of salivary glands, Ann. Surg. Oncol, 16, 751, 10.1245/s10434-008-0259-6

Sica, 2012, Macrophage plasticity and polarization: in vivo veritas, J. Clin. Invest, 122, 787, 10.1172/JCI59643

Sierra, 2008, Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages, J. Exp. Med, 205, 1673, 10.1084/jem.20072602

Skobe, 2001b, Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma, Am. J. Pathol, 159, 893, 10.1016/S0002-9440(10)61765-8

Skobe, 2001a, Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis, Nat. Med, 7, 192, 10.1038/84643

Song, 2013, Lenalidomide inhibits lymphangiogenesis in preclinical models of mantle cell lymphoma, Cancer Res, 73, 7254, 10.1158/0008-5472.CAN-13-0750

Stacker, 1999, Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers, J. Biol. Chem, 274, 32127, 10.1074/jbc.274.45.32127

Staples, 2011, Monocyte-derived macrophages matured under prolonged hypoxia transcriptionally up-regulate HIF-1alpha mRNA, Immunobiology, 216, 832, 10.1016/j.imbio.2010.12.005

Storr, 2012, Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma, Mod. Pathol, 25, 493, 10.1038/modpathol.2011.182

Stout, 2004, Functional plasticity of macrophages: reversible adaptation to changing microenvironments, J. Leukoc. Biol, 76, 509, 10.1189/jlb.0504272

Stout, 2009, Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages, J. Leukoc. Biol, 86, 1105, 10.1189/jlb.0209073

Takanami, 1999, Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis, Oncology, 57, 138, 10.1159/000012021

Takao, 1998, Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas, Clin. Cancer Res, 4, 1619

Tammela, 2008, Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation, Nature, 454, 656, 10.1038/nature07083

Tjiu, 2009, Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction, J. Invest. Dermatol, 129, 1016, 10.1038/jid.2008.310

Toi, 1999, Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer, Clin. Cancer Res, 5, 1131

Torisu, 2000, Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha, Int. J. Cancer, 85, 182, 10.1002/(SICI)1097-0215(20000115)85:2%3C182::AID-IJC6%3E3.3.CO;2-D

Vacca, 1999, Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas, Br. J. Cancer, 79, 965, 10.1038/sj.bjc.6690154

Valkovic, 2002, Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma, Virchows Arch, 440, 583, 10.1007/s004280100458

Wang, 2008, YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease, Scand. Cardiovasc. J, 42, 295, 10.1080/14017430802220567

Welford, 2011, TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice, J. Clin. Invest, 121, 1969, 10.1172/JCI44562

Werchau, 2012, Merkel cell carcinoma induces lymphatic microvessel formation, J. Am. Acad. Dermatol, 67, 215, 10.1016/j.jaad.2011.09.002

Werno, 2010, Knockout of HIF-1alpha in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses, Carcinogenesis, 31, 1863, 10.1093/carcin/bgq088

Whitehurst, 2007, Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model, Int. J. Cancer, 121, 2181, 10.1002/ijc.22937

Wu, 2012, Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer, J. Surg. Oncol, 106, 462, 10.1002/jso.23110

Wyckoff, 2004, A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors, Cancer Res, 64, 7022, 10.1158/0008-5472.CAN-04-1449

Xu, 2013, CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer, Cancer Res, 73, 2782, 10.1158/0008-5472.CAN-12-3981

Yamac, 2008, Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer, Adv. Ther, 25, 801, 10.1007/s12325-008-0082-2

Yang, 2011, Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer, Mol. Cancer, 10, 36, 10.1186/1476-4598-10-36

Yao, 2005, Autocrine and paracrine regulation of interleukin-8 expression in lung cancer cells, Am. J. Respir. Cell Mol. Biol, 32, 540, 10.1165/rcmb.2004-0223OC

Yao, 2001, Macrophage infiltration-associated thymidine phosphorylase expression correlates with increased microvessel density and poor prognosis in astrocytic tumors, Clin. Cancer Res, 7, 4021

Zhang, 2011b, M2-polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma, Clinics (Sao. Paulo), 66, 1879, 10.1590/S1807-59322011001100006

Zhang, 2012b, M2-polarized macrophages promote metastatic behavior of Lewis lung carcinoma cells by inducing vascular endothelial growth factor-C expression, Clinics (Sao. Paulo), 67, 901, 10.6061/clinics/2012(08)08

Zhang, 2012a, Secreted protein acidic and rich in cysteine (SPARC) suppresses angiogenesis by down-regulating the expression of VEGF and MMP-7 in gastric cancer, PLoS ONE, 7, e44618, 10.1371/journal.pone.0044618

Zhang, 2011a, Survey of risk factors contributed to lymphatic metastasis in patients with oral tongue cancer by immunohistochemistry, J. Oral Pathol. Med, 40, 127, 10.1111/j.1600-0714.2010.00953.x

Zumsteg, 2009, Myeloid cells contribute to tumor lymphangiogenesis, PLoS ONE, 4, e7067, 10.1371/journal.pone.0007067